March 30, 2020

IAVI's response to the COVID-19 pandemic


IAVI remains committed to ensuring the safety of volunteers and staff in our clinical trials. We have worked closely with our staff and partners to follow guidance issued by public health authorities and government officials in this rapidly changing environment.

Accordingly, IAVI-sponsored clinical trials that had recently been recruiting, screening, and/or enrolling volunteers have put those activities on hold for the time being. Similarly, trials that were scheduled to begin those activities have put them on hold.

Most trials are currently continuing volunteer follow up per trial protocol, with infection containment restrictions being practiced at the local trial sites. For some trials, trial staff are contacting volunteers by other methods such as telephone follow up.

We continue to assess the situation with the aim of ensuring the safety of our volunteers, staff, and partners. In the meantime, we are also working with partners to identify opportunities to contribute our expertise and resources to COVID-19 response.

Visit our Coronavirus Response page to learn more about how we're responding to COVID-19 across our program areas and to access helpful resources from the broader global health field.

 

Media Contacts

Africa

Ethel Makila
+254 71 904 3142
EMakila@iavi.org 

 

Europe

Hester Kuipers
+31 20 521 0343
HKuipers@iavi.org 

 

India

Saif ul Hadi
+91 11 4737 6032
SulHadi@iavi.org 

 

North America

Rose Catlos
+1 212 847 1049
RCatlos@iavi.org